Related by context. Frequent words. (Click for all words.) 75 sNDA 72 sBLA 70 Biologics License Application BLA 69 supplemental Biologics License Application 67 Biologics License Application 66 Marketing Authorization Application MAA 65 FDA approvable letter 64 Act PDUFA date 64 NUVIGIL 64 BLA submission 64 FDA Accepts 64 Marketing Authorization Application 63 Drug Application 63 Pirfenidone 63 Extended Release Tablets 63 Panzem R 62 dalbavancin 62 SPD# 62 Hycamtin 62 Seroquel XR 62 New Drug Application 62 Avastin bevacizumab 62 Oral Solution 62 Clevudine 62 Irinotecan 62 Icatibant 61 Promacta 61 Pivotal Phase III 61 clofarabine 61 Vilazodone 61 PRISTIQ 61 Rebif ® 61 mTOR inhibitor 61 Market Approval PMA 60 elotuzumab 60 anticancer compound 60 TREANDA 60 KRN# 60 metastatic hormone refractory 60 pseudobulbar affect PBA 60 Mipomersen 60 thymalfasin 60 Traficet EN 60 Omigard 60 Phase III Clinical Trial 60 SEROQUEL XR 60 alvimopan 60 Vandetanib 60 LIALDA 60 Zelrix 60 orphan designation 60 Topiramate 60 R sorafenib tablets 60 Saphris 60 Natalizumab 60 Oxaliplatin 60 Presents Positive 60 Marqibo 59 Jevtana 59 Laquinimod 59 Complete Response 59 Nasdaq VRTX 59 Abstral 59 alogliptin 59 Completes Enrollment 59 Neurodex 59 PREOS 59 Nexavar ® 59 injection USP 59 REVLIMID lenalidomide 59 investigational oral 59 Clolar 59 Zolinza 59 Zalbin 59 Orphan Drug designation 59 Relistor 59 Solzira 59 Amrubicin 59 romiplostim 59 rNAPc2 59 QNEXA 59 registrational 59 methylnaltrexone 59 MONOVISC 58 Orphan Drug status 58 Arixtra 58 Drug Candidate 58 IND submission 58 LIVALO 58 Clinical Trial Results 58 liprotamase 58 Invega 58 Frova 58 Focalin XR 58 integrase inhibitor 58 Anastrozole 58 FUSILEV 58 Torisel 58 USFDA approval 58 MNTX 58 Extended Release